September 30, 2025

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 115% Potential Upside for Savvy Investors

Innoviva, Inc. (INVA), a biotechnology company based in Burlingame, California, is making waves in the healthcare sector with its promising stock potential. With a market cap of $1.2 billion and..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 32.91% Potential Upside in the Healthcare Sector

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Pleasanton, California, this life science technology company has..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 146.60% Upside Amidst Market Challenges

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, offers a diverse portfolio in diagnostics and pharmaceuticals that caters to both domestic and international markets. Despite experiencing..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Innovator with a 31% Potential Upside

Tarsus Pharmaceuticals, Inc. (TARS) is capturing the attention of investors with its compelling growth narrative and significant market potential in the healthcare sector. As a commercial-stage biopharmaceutical company, Tarsus focuses..

Liquidia Corporation (LQDA) Stock Analysis: Biotechnology Innovator Shows 60.82% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the biotechnology industry, stands out with a robust 60.82% potential upside according to analyst ratings. As the company continues to innovate in..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Promising 117% Upside in the Biotechnology Sector

Vera Therapeutics, Inc. (NASDAQ: VERA) is positioning itself as a potentially high-reward player in the biotechnology sector, with its focus on developing transformative treatments for serious immunological diseases. With a..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 5.87% Potential Upside in the Dental Industry

Envista Holdings Corporation (NYSE: NVST) is a notable player within the healthcare sector, specifically focusing on the medical instruments and supplies industry. With a market capitalization of $3.38 billion, the..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a Potential 16.47% Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.06 billion, the company..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 231% Potential Upside in Biotech

Janux Therapeutics, Inc. (NASDAQ: JANX), a pioneer in the field of biopharmaceuticals, has been turning heads in the investment community with its innovative approach to cancer treatment and a staggering..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Valuation and Growth Prospects Amidst Analyst Optimism

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s niche of medical instruments and supplies, has been making waves with its unique business model and innovative approach..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 127.89% Potential Upside

89bio, Inc. (NASDAQ: ETNB) is making waves in the biotechnology sector with its promising pipeline in the treatment of liver and cardio-metabolic diseases. With a market capitalization of $2.18 billion..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 224.67% Potential Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN) stands as a compelling player in the biotechnology sector, offering a promising yet complex profile for investors seeking growth investments. With a market cap of $1.59..

GRAIL, Inc. (GRAL) Stock Analysis: High Current Price Amidst Downside Risks

GRAIL, Inc. (NASDAQ: GRAL) has emerged as a significant player in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $2.12 billion, GRAIL is..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 26% Potential Upside in the Biopharmaceutical Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has increasingly captured the attention of investors in the healthcare sector. With its focus on developing novel therapies for cardiovascular and other diseases with unmet..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring an 82.96% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands as a dynamic player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $810.83 million, the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 7.4% Potential Upside in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, particularly in the medical care facilities industry, has been garnering attention from investors seeking opportunities in the..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 53% Potential Upside Amidst a Biotech Revolution

For investors eyeing the healthcare sector, Disc Medicine, Inc. (NASDAQ: IRON) presents a compelling opportunity. With a focus on addressing unmet needs in hematologic diseases, this clinical-stage biopharmaceutical company might..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring the 36% Revenue Growth and Future Prospects

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands as a notable player in the burgeoning biotechnology sector, captivating investors with its robust growth trajectory and innovative approaches to healthcare. Headquartered in Seattle,..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Analyzing a 23.60% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine technologies. As a company focused on developing cutting-edge solutions for medical challenges, Pulse..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Biotechnology Innovator with 11.18% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is generating buzz in the biotechnology sector, offering investors a unique opportunity to engage with a company at the cutting edge of healthcare innovation. With..

Search

Funds

September 30, 2025

Search

Funds

September 30, 2025

FTSE 100

Funds